MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
2. Industry_Business Architects & Consolidators
Industry: By Region (Globally)
Industry: U.S.(United States)
Industry: SouthEast
*Industry: Virginia
CEL-SCI Corporation (NYSE: CVM)
Organization & Developments: Cel-Sci
Parents
CEL-SCI Corporation (NYSE: CVM)
Children
*CEL-SCI Corporation is developing products that empower immune defenses.
2010: CEL-SCI COMMENCES PHASE III CLINICAL TRIAL IN HEAD AND NECK CANCER (2010)
2019: Cel-Sci's Phase 3 Multikine Trial Has 'Not Yet Hit The Primary Endpoint'_seekingalpha.com
2020: Cel-Sci: Little Known Drug Validates Multikine's Investigation Goals_seekingalpha.com
2020: Cel-Sci: The Upside Is Still There_seekingalpha.com
2022: CEL-SCI: More Shareholder Pain Likely Ahead_ seekingalpha.com
2022: CEL-SCI: No Rush Here_seekingalpha.com
2022: CEL-SCI's Multikine - Potential 21st Century Game-Changing Cancer Drug On The Horizon_seekingalpha.com
2024: Cel-Sci: Fabulous Story Stock Works To Pass Muster With FDA
Jumps
*Key People: Cel-Sci
Finance & Acquisitions: Cel-Sci